Saltar al contenido
Merck

Sodium bicarbonate: basically useless therapy.

Pediatrics (2008-10-03)
Judy L Aschner, Ronald L Poland
RESUMEN

Common clinical practices often are unsupported by experimental evidence. One example is the administration of sodium bicarbonate to neonates. Despite a long history of widespread use, objective evidence that administration of sodium bicarbonate improves outcomes for patients in cardiopulmonary arrest or with metabolic acidosis is lacking. Indeed, there is evidence that this therapy is detrimental. This review examines the history of sodium bicarbonate use in neonatology and the evidence that refutes the clinical practice of administering sodium bicarbonate during cardiopulmonary resuscitation or to treat metabolic acidosis in the NICU.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Bicarbonato de sodio, ACS reagent, ≥99.7%
Sigma-Aldrich
Bicarbonato de sodio, powder, BioReagent, Molecular Biology, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Bicarbonato de sodio, ReagentPlus®, ≥99.5%, powder
Sigma-Aldrich
Sodium bicarbonate solution, solution (7.5%), sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
Bicarbonato de sodio, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E500, 99.0-100.5%, powder
Sigma-Aldrich
Bicarbonato de sodio, BioXtra, 99.5-100.5%
USP
Bicarbonato de sodio, United States Pharmacopeia (USP) Reference Standard
Supelco
Sodium bicarbonate concentrate, 0.1 M NaHCO3 in water, eluent concentrate for IC
Sigma-Aldrich
Bicarbonato de sodio, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Bicarbonato de sodio, −40-+140 mesh, ≥95%
Sigma-Aldrich
Bicarbonato de sodio, tested according to Ph. Eur.
Sigma-Aldrich
Sodium bicarbonate-12C, 99.9 atom % 12C